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Breathing is essential to provide the O2 required for metabolism and to remove its inevitable CO2 by 
product. The rate and depth of breathing is controlled to regulate excretion of CO2 to maintain the 
pH of arterial blood at physiological values. A widespread consensus is that chemosensory cells in 
the carotid body and brainstem measure blood and tissue pH and adjust the rate of breathing to 
ensure its homeostatic regulation. In this review, I shall consider the evidence that underlies this 
consensus and highlight historical data indicating that direct sensing of CO2 also plays a significant 
role in the regulation of breathing. I shall then review work from my laboratory which provides a 
molecular mechanism for the direct detection of CO2 via the gap junction protein connexin26 (Cx26) 
and demonstrates the contribution of this mechanism to the chemosensory regulation of breathing.  
As there are many pathological mutations of Cx26 in humans, I shall discuss which of these alter the 
CO2 sensitivity of Cx26 and the extent to which these mutations could affect human breathing. I 










1. Blood gases and breathing  
 
We breathe for two essential purposes: the first is to provide oxygen required for metabolism. 
Adenosine triphosphate (ATP) is the universal store of chemical energy that is used to drive the 
energetically unfavourable reactions essential for life. To produce ATP via oxidative phosphorylation, 
we need a constant supply of oxygen. For example, the complete metabolism of one molecule of 
glucose to CO2 and H2O, requires 6 molecules of O2 and produces 36 molecules of ATP. Without 
this steady supply of O2, metabolism would grind to a halt, with ultimately fatal consequences. 
However, there is a second essential purpose of breathing: to remove CO2. The complete 
metabolism of one molecule of glucose, produces 6 molecules of CO2. In fact, adult humans excrete 
about 20 moles (or ~880 g) of CO2 per day. If this were to accumulate in the body, the pH of blood 
and other fluids would become highly acidic. This is because CO2 and H2O can be readily combined 
by the enzyme carbonic anhydrase (CA) to generate carbonic acid, which rapidly and spontaneously 
dissociates into a hydrogen ion and a bicarbonate ion: 
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The excretion of CO2 is thus the second essential function of breathing. As air breathing organisms, 
we face an abundance of O2 compared to water breathing organisms: one litre of air contains about 
210 ml of O2; by comparison one litre of water at 15 °C will contain only about 7 ml of dissolved O2. 
For air breathing animals, oxygen is not a limiting gas; instead the key to survival is the rate at which 
CO2 can be removed from blood via breathing. The complete opposite is true for water breathing 
organisms where O2 is severely limiting and CO2 is very readily excreted. As might be expected 
therefore, water breathing animals largely regulate breathing rates by measuring the partial pressure 
of O2 (PO2), and the ventilation rate of air breathing animals depends primarily on the level of partial 
pressure of CO2 in arterial blood (PaCO2) (1). This fundamental importance of CO2 and its primacy 
over O2 for the regulation of breathing in humans was first established in 1905 by Haldane and 
Priestley (2). 
 
Equation 1 shows that CO2 could exert its effect in three possible ways: as molecular CO2; as pH or 
as HCO3-. Note that these mechanisms of action are not mutually exclusive. A consensus has 
emerged, reflected in many textbooks on the subject, that changes in pH are a sufficient stimulus for 
the detection of changes in PaCO2 and the consequent actions on breathing. The pH chemosensory 
hypothesis is made plausible by an abundance of potential molecules available to transduce 
changes in pH. Although all proteins will be sensitive to pH to some extent, some ion channels and 
receptors are especially sensitive over a range (pH 7.5 – 6.9) that is physiologically relevant to 
chemosensory regulation. These include the TASK potassium channel family (3), heteromeric 
Kir4.1-Kir5.1inward rectifier K+ channels (4), the acid sensing cation channels (ASICs) (5, 6) and G-
protein coupled receptors such as GPR4, which can stimulate cAMP production in a pH-dependent 
manner (7). 
 
Nevertheless, there is longstanding evidence that matters are not quite this simple. Eldridge et al (8) 
showed that the ventilatory response in cats to inspired CO2 was greater than the response to an 
equivalent imposed change in pH at constant PaCO2. In their discussion, they proposed the following 
hypothesis (which they favoured over competing explanations): 
 
“ … there is an action of molecular CO2 that is independent of its effects on e.c.f. [H+]. This 
would have to mean that there are two types of receptor sites on the chemosensory cells, or 
that [H+] effects come from locations in the medulla that are separate from the cells that 
respond to CO2. Both of these possibilities would imply that during hypercapnia some of the 
respiratory response is due to the CO2 effect and some to the simultaneously generated [H+].” 
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In a highly complementary study, Hashim Shams measured both pH and PCO2 at the ventral surface 
of the medulla oblongata of the cat (the site of a major component of central chemoreception) while 
infusing bicarbonate ions into the blood at a rate sufficient to keep the pH constant at the surface of 
the medulla during the inhalation of CO2 (9). He found that there was still an increase in breathing 
proportional to PCO2 even when extracellular pH was kept constant. When pH was allowed to vary 
in addition to CO2 (i.e. no compensating infusion of bicarbonate into the blood) the increase in 
breathing was roughly double that which occurred during the change in PCO2 at constant pH. From 
this Shams concluded that:  
 
“… both H+ and CO2 in interstitial fluid of the ventral medulla oblongata independently stimulate 
the areas responsible for central chemosensitivity”. 
 
The key implications arising from both of these papers are that: i) there are separate molecular 
mechanisms for the detection of pH and CO2 and that both are involved in the regulation of 
breathing; and ii) there may be separate cells and/or chemosensitive nuclei that specialize in pH 
detection or CO2 detection. In this review, I will summarize data that establishes both a molecular 
mechanism for the detection of CO2 and the cellular types and areas that appear to perform this 
function for the regulation of breathing. In so doing, I will give strong support to the far-sighted 
hypotheses of these authors. 
 
2. Mechanisms underlying the chemosensory control of breathing 
 
2.1 Peripheral versus central 
 
There are two main locations for the detection of the CO2-linked stimuli that control breathing: the 
carotid body, and the medulla oblongata in the brain stem (Figure 1). Fernando de Castro (10) 
suggested that glomus cells within the carotid bodies may detect changes in the composition of the 
blood. Cornelius Heymans then showed that the carotid bodies could regulate breathing frequency 
in response to acidosis (via the glomus cell chemoreceptors) (11). The carotid bodies contribute 
about 30% of the total response to alterations in PaCO2 (12-14). By utilizing a perfusion technique 
to control PaCO2, PaO2 and pH around the brain stem chemosensors independently from that of the 
peripheral chemosensors, Schuitmaker et al., (15) established that ventilation was a function only of 
peripheral pH and not of peripheral PaCO2 providing strong evidence that the carotid body 
chemoreceptors detect changes in pH rather than changes in PaCO2. We now know that carotid 
body glomus cells use TASK-1 channels, which are pH sensitive, to detect the changes in blood pH 
that accompany hypercapnia (16) (Figure 1). Some residual pH sensitivity remains in carotid glomus 
cells in TASK-1 null mice (16), suggesting that a further molecular transducer must also contribute 
such as GPR4, which is present in the carotid body (17). Central chemosensitivity is unaffected by 
TASK-1 deletion (18).  
 
The importance of the medulla oblongata, was recognized following the pioneering work of the 
Mitchell (19) and Loeschcke (20) laboratories. These studies showed that the ventral surface of the 
medulla oblongata is a key site of chemoreception and that 3 distinct locations (rostral, intermediate 
and caudal, also respectively called M, S and L areas) are involved. The rostral area is ventral to the 
7th nucleus and the retrotrapezoid nucleus (RTN), more recently implicated in chemosensory control, 
corresponds at least partly to this area (Figure 1). The raphé magnus is also ventral and medial to 
the 7th nucleus and contains pH-sensitive serotonergic neurons that may be involved in the 
chemosensory control of breathing (Figure 1). The raphé would thus correspond to the more medial 
regions of the historically-identified rostral area. The caudal area is close to the nerve rootlets of the 
12th nerve and the intermediate area is a small region just anterior to the most anterior rootlet of the 
12th nerve. A variety of evidence suggested their importance. Local acidosis of the rostral and caudal 
areas stimulated breathing via an increase in tidal volume (21). Destructive coagulation of these 
areas greatly reduced the sensitivity of breathing to CO2 (22). Electrical stimulation of these areas 





2.2 pH-sensitive mechanisms 
 
 
More recent studies have explored the role of the RTN in chemosensory processes (17, 24-27). 
Some RTN neurons are intrinsically pH-sensitive and the expression of two molecules in these 
neurons may contribute to chemosensory control of breathing: TASK-2, a pH-sensitive K+ channel 
(17, 28); and GPR4, a pH-sensitive receptor (17). However, GPR4 is widely expressed in neurons 
including those of the medullary raphé, peripheral chemosensors, as well as the endothelium (29). 
While a contribution of GPR4 to chemosensory regulation seems likely, its specific role in the RTN 
is open to question. Systemic injection (i.e. will affect both peripheral and central chemosensors) of 
a selective and potent GPR4 antagonist reduced the ventilatory response to CO2. This same 
antagonist when administered centrally (only affecting central chemosensors) had no effect on the 
CO2-sensitivity of breathing (29). 
 
Medullary raphé neurons (both serotonergic and non-serotonergic) are sensitive to pH (30-35) and 
are highly likely to contribute to respiratory chemosensitivity. Consistent with this role, raphé neuron 
processes are in close proximity to blood vessels (36). Most compellingly, selective chemogenetic 
silencing of serotonergic raphé neurons reduced by 40% the increase in minute ventilation evoked 
by hypercapnia (37). The RTN and raphe are likely to act in concert. Chemosensory responses in 
RTN neurons depend partially on serotonergic inputs from raphé neurons (38) and this suggests 
that RTN neurons, in addition to being intrinsically pH-sensitive, may act as relays of chemosensory 
information. 
 
Leaving aside the relative contributions of the RTN and medullary raphé and their possible 
interactions, the evidence points to at least some of the primary chemosensory cells in both of these 
nuclei being neurons that utilize pH-sensitive channels or receptors to detect changes in pH and 
regulate breathing (Figure 1). These cells would therefore correspond to the pH-sensitive pillar of 
central chemosensory detection postulated by Eldridge et al (8) and Shams (9) more than 30 years 
ago. 
 
2.3 ATP-dependent mechanisms respiratory chemosensitivity -a potential role for connexin 
hemichannels in the regulation of breathing 
 
In areas of the ventral medullary surface that correspond to the rostral and caudal chemosensory 
regions, hypercapnia will induce release of ATP that precedes any adaptive changes in breathing 
(39). This ATP release contributes to the adaptive regulation of breathing to hypercapnia because 
application of ATP receptor antagonists will blunt these changes (39). The location of CO2-
dependent ATP release at the medullary surface closely corresponds to the distribution of raphé 
neurons (39, 40). The hypercapnic ATP release might therefore contribute to excitation of the raphé 
neurons. However there is conflicting data on this point (41, 42), which remains to be resolved, 
possibly through use of more potent ATP receptor antagonists that are now available. 
 
Given that ATP release occurs very early after the onset of hypercapnia and before any changes in 
breathing, it is plausible to speculate that it may arise from chemosensory cells. This CO2-dependent 
ATP release can be recapitulated in vitro in an isolated slice of the ventral medullary surface (43). 
Under these controlled conditions, ATP release was evoked by an increase in PCO2 at constant 
extracellular pH (achieved by also increasing HCO3-) (43) and shares this characteristic with the 
CO2-dependent regulation of breathing discovered by Shams (9). The ATP release occurred in both 
the rostral and caudal chemosensory regions, and was independent of extracellular Ca2+ (43). By 
examining the distribution of connexins, Huckstepp et al (43) discovered that Cx26 was preferentially 
localized in the ventral medulla, and was in fact expressed not in neurons but in glial cells of the 
marginal zone at the ventral surface of the medulla. This localisation of Cx26 to glial cells is 
consistent with a wide variety of evidence suggesting that Cx26 is largely absent from neurons and 
is only expressed in a subset of astrocytes, mainly those close to the margins of the parenchyma 
(44-46). As a variety of connexin hemichannels have been documented to permit the release of ATP 
from cells (47-49), Cx26 hemichannels were a favoured candidate for the release of ATP during 
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hypercapnic stimuli. A range of pharmacological agents with selectivity towards connexins blocked 
the CO2 dependent ATP release observed in vitro, suggesting that the ATP release may indeed be 
mediated via gating of connexin hemichannels (43). These pharmacological agents were somewhat 
selective for Cx26. These same agents, when used in vivo, reduced the adaptive ventilatory 
response to CO2 by a similar amount to blockade of ATP receptors (~20%) and reduced the 
observed CO2-evoked ATP release, supporting the involvement of Cx26 in the chemosensory control 
of breathing (43). 
 
This evidence implicating Cx26 in the CO2-dependent release of ATP during hypercapnia, raised the 
possibility that Cx26 might itself be CO2 sensitive. Expression of Cx26 in HeLa cells caused these 
cells to exhibit a CO2-dependent conductance increase that was absent from parental HeLa cells 
(50). The presence of Cx26 also permitted CO2-dependent dye loading into, and CO2-dependent 
ATP release from, HeLa cells (50). These actions of CO2 (performed at constant extracellular pH) 
cannot be explained as an effect of intracellular pH, as acidification is well known to close Cx26 
hemichannels (51). Furthermore, CO2 still gated Cx26 in isolated membrane patches where pH could 
be controlled on both sides of the membrane (50). The simplest interpretation of these data is that 
Cx26 is itself directly sensitive to CO2. Binding of CO2 to Cx26 hemichannels causes them to open, 
thus permitting the ATP release, which by acting as a transmitter can mediate adaptive changes in 
breathing via ATP-sensitive receptors. Glial cells expressing Cx26 in the ventral medulla could 
comprise the cellular basis of the direct CO2 sensing involved in the control of breathing described 
by Eldridge et al (8) and Shams (9). 
 
There is a further potential mechanism of astrocytic pH sensing to consider. Astrocytes in the RTN 
can release ATP in a pH-dependent manner and influence the rate of breathing thus potentially 
contributing to the adaptive control of breathing (52). This pH-dependent release of ATP depends 
on a process involving activation of the sodium bicarbonate transporter (NBCe1) and reversed Na+-
Ca2+ exchange (53). 
 
2.4 The direct action of CO2 on Cx26 
 
It is possible that the opening effect of CO2 on Cx26 in HeLa cells could be indirect and mediated 
via a second protein. The observation that modulation of Cx26 could be observed in isolated patches 
makes this possibility rather unlikely, but does not eliminate it. The most convincing evidence to 
demonstrate a direct action of CO2 on Cx26 would be to demonstrate the ability of mutations of Cx26 
to change its CO2 sensitivity, and ultimately to uncover the mechanism by which CO2 has this action 
on Cx26. 
 
Three closely related connexins (Cx26, Cx30 and Cx32) are sensitive to CO2 (50) and ATP can 
permeate the hemichannels of all three of these connexins (50, 54, 55). To investigate possible 
mechanisms of CO2 sensitivity, we looked for a further related connexin that might not have this 
sensitivity. The idea being that differences in amino acid sequences between the CO2-sensitive 
connexins and a further non-CO2-sensitive, but related, connexin might illuminate the structural 
features underlying the interaction with CO2. We chose Cx31, and found that it lacked sensitivity to 
CO2. Our starting supposition for sequence comparison was that CO2 might carbamylate a lysine 
residue (50). This is a post-translational protein modification that has largely been overlooked in 
mammalian physiology. CO2 carbamylation was originally described as the basis of the Bohr effect 
whereby CO2 reduces the affinity of haemoglobin for O2 enabling it to give up its oxygen to tissue 
(56). Carbamylation of lysine residues has also been established in RuBisco (57), a key enzyme for 
photosynthetic carbon fixation, and in microbial beta-lactamases (58, 59). The idea that 
carbamylation might be a general and important post-translational protein modification involved in 
physiological regulation was first proposed by George Lorimer (60) and more recently discussed by 
Louise Meigh (61). This concept can now be explored in a systematic manner via mass spectrometric 
tools developed by Martin Cann and his team (62). 
 
We compared the sequences of Cx26, Cx30, Cx32 and Cx31, looking for lysine residues that might 
be present in the three CO2 sensitive connexins but absent from Cx31. This revealed a lysine residue 
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and a motif specifically present in the CO2 sensitive connexins (63). We were tremendously aided 
by an X-ray structure for Cx26 (64), which showed the residues of the motif that we had identified 
and which we termed the carbamylation motif. The structure showed that the lysine within the motif, 
K125, is oriented towards R104 in the neighbouring subunit of the hexamer (Figure 2). The gap 
between the end of the sidechains of the two residues is only 6.5 Å, making it plausible to think that 
carbamylation of K125 might allow formation of a salt bridge between this residue and R104 to form 
a “carbamate bridge” between subunits. To provide support for this hypothesis, we simply 
transplanted the carbamylation motif into Cx31 and demonstrated that it gave a gain of CO2 
sensitivity (63). Mutations of the residues K125 and R104 were then made to further test our 
hypothesis: for example, K125R (arginine not being carbamylatable) destroyed CO2 sensitivity in 
Cx26, as did R104A (removing the ability to make a salt bridge) (63). The mutations K125E or R104E 
gave a constitutively open hemichannel that was no longer sensitive to CO2 (63). The mutation 
K125C gave a hemichannel that could be opened by NO -by nitrosylation of the cysteine residue 
and formation of a bridge to R104 (65), and the double mutation K125C and R104C gave a 
hemichannel that was redox sensitive (65). 
 
To summarize, our data definitively show that CO2 has a direct action on Cx26, as mutations of the 
protein alter its sensitivity to CO2 and can even be used to introduce sensitivity to new ligands. Our 
data very strongly suggest that CO2 carbamylates a specific lysine residue to cause conformational 
change and opening of the hemichannel. The very small possibility that CO2 has this effect by some 
other, as yet unknown, mechanism consistent with our mutational analysis can only be eliminated 
by direct demonstration of carbamylation e.g. by mass spectrometry methods. 
 
2.5 From structural biology to tools to probe CO2 sensing via Cx26 
 
We have exploited our understanding of how CO2 binds to, and modulates, Cx26 by developing a 
dominant negative subunit, dnCx26. This subunit carries two mutations: R104A and K125R. The first 
mutation prevents formation of intersubunit carbamate bridges, while the second prevents binding 
of CO2. Homomers of dnCx26 (as would be expected) are insensitive to CO2. We have shown, via 
fluorescence resonance energy transfer, that dnCx26 assembles very efficiently into hexamers with 
wild type Cx26 (66). HeLa cells that stably express Cx26 (and will dye load in response to CO2), 
when transfected with dnCx26 lose their CO2 sensitivity (66). Thus, dnCx26 does indeed act as a 
dominant negative subunit and can remove CO2 sensitivity from the endogenously expressed wild 
type Cx26 (66). This makes it a very selective genetic tool to probe the contribution of CO2 sensing 
via Cx26 to physiological processes -indeed it links the motif of CO2 binding to physiological action.  
 
2.6 Genetic evidence for Cx26 and the control of breathing 
 
To exploit dnCx26 as a tool to probe the control of breathing, we generated lentiviral constructs in 
which a GFAP promoter was used to drive the expression of either wild type Cx26 or dnCx26 
followed by an IRES and Clover. Clover is a highly fluorescent green protein and this strategy 
allowed us to ascertain the expression pattern of our Cx26 constructs without directly tagging the 
protein which might alter its expression in vivo. When injected into the ventral medulla of the adult 
mouse, the lentiviral constructs drove selective expression of Cx26 and dnCx26 in GFAP+ cells. The 
location of expression of dnCx26 was critical. When expressed in the RTN, dnCx26 had no effect on 
the CO2-sensitivity of breathing (66). Although Cx26 is expressed in this area, it does not contribute 
to the regulation of breathing and may have some other function. When dnCx26 was expressed 
caudally in a small area called the caudal parapyramidal area (cPPy) it altered the CO2 sensitivity of 
breathing (66). dnCx26 had no effect on the adaptive change in respiratory frequency, but instead 
reduced the adaptive change in tidal volume at moderate levels of inspired CO2. Expression of 
dnCx26 reduced the change in tidal volume and minute ventilation by about 33% compared to 
expression of the Cx26 wild type subunit (as a control). When expressed even more caudally, 
dnCx26 once again had no effect on breathing. Thus, it appears that there is a specific, defined area 
where the presence of Cx26 mediates CO2-dependent regulation of breathing (Figure 3). We 
suggest that the glial cells of the cPPy correspond to the chemosensory cells responsible for the 
direct detection of CO2 first hypothesised by Eldridge et al (8) and Shams (9). 
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The cPPy has been implicated in the chemosensory control of breathing (67, 68). These previous 
studies demonstrated the presence of highly pH sensitive serotonergic cells in this area. This raises 
the fascinating possibility that the CO2 detection mediated by superficial glial cells that express Cx26, 
converges with pH detection mediated by colocated serotonergic neurons in the cPPy. A further 
point of interest is that the key glial cells in the cPPy had an unusual morphology: a very superficial 
cell body and a long process that projected both rostrally and medially (66). 
 
2.7 Cx26-mediated chemosensing in context 
 
As stated earlier peripheral (carotid body) and central chemoreceptors mediate the CO2-dependent 
control of breathing with the former contributing ~30% of the total chemosensory response (12-14). 
There are two components to the adaptive changes in ventilation - an increase in respiratory 
frequency, and an increase in tidal volume. These two components combine to increase the rate of 
ventilation of the lungs: minute ventilation. Broadly, peripheral chemoreceptors appear primarily to 
increase respiratory frequency, whereas activation of central chemoreceptors has a more powerful 
effect on tidal volume (21, 69, 70). 
 
Within this overall context (Figure 3), how significant is CO2 sensing via Cx26? Viral transduction by 
dnCx26 reduced the mean adaptive ventilatory response to 6% inspired CO2 by about one third - 
mainly via a reduction of the increase in tidal volume. As we were unlikely to transduce all of the 
chemosensitive glial cells in this area, this may be an underestimate of the contribution of this 
mechanism. As central chemoreceptors mediate about 70% of the adaptive response, CO2 sensing 
via Cx26 in the caudal parapyramidal area mediates nearly half of the total central ventilatory 
response to modest levels of hypercapnia. This compares favourably to the roughly 50% contribution 
of direct CO2 sensing to the regulation of breathing via central chemosensors proposed by Shams 
(9) and suggests that Cx26 in the cPPy may mediate the majority of this component. This contribution 
of Cx26 to the hypercapnic regulation of breathing is broadly comparable to the chemogenetic 
inactivation of the entire population of raphé serotonergic neurons (including those in the midbrain 
and in the medulla oblongata), which gave a 40% reduction in the adaptive ventilatory response at 
similar levels of inspired CO2 (37).  
 
Cx26-mediated chemosensing adds a further dimension to the regulation of breathing beyond its 
proportional contribution to the adaptive reflex to hypercapnia. Although the concentrations of CO2, 
HCO3- and H+ are interdependent (Equation 1), local buffering of HCO3- and H+ (53) via a variety of 
membrane exchangers and transporters (71, 72) can alter both the spatial and temporal dynamics 
of these potential chemosensory signals. The ability to sense CO2 directly, via Cx26, provides 
additional information to determine changes in PCO2 more accurately than measurement of pH alone 
(73). Direct measurement of CO2 might be important during modest levels of hypercapnia, where 
the systemicl pH change will not be large and the actions of transporters and exchangers could 
locally buffer pH and thus potentially obscure this signal. 
 
3. Cx26 and breathing in humans 
 
Roughly 1-3 per 1000 people have some form of congenital hearing loss. Mutations in Cx26 account 
for about half of these cases (74). In Caucasian populations the mutations G30del and G35del, which 
cause loss of functional protein, are the most common and have a prevalence conservatively 
estimated as around 1:5000 of the general population. In addition to the non-syndromic (and mostly 
recessive) mutations that cause hearing loss, there are 9 further dominant mutations that cause a 
severe condition termed Keratitis, Ichthyosis, Deafness Syndrome (KIDS) (75, 76). These mutations 
are very rare and mostly are idiopathic. In addition to profound hearing loss, KIDS involves skin 
defects that result in the severest case in loss of the dermal barrier and problems in the eye including 
corneal defects and photophobia. 
 
Naveed Hussain and Dan Mulkey, treating an infant carrying the Cx26 mutation A88V, which gives 
a severe form of KIDS, observed and documented that the infant suffered from periods of central 
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apnoea (77). When they brought this to our attention, we engineered this mutation into Cx26 (Figure 
4) and found that it completely abolished the CO2 sensitivity of the resulting hemichannel. 
Furthermore, Cx26A88V had a dominant negative effect on the CO2 sensitivity of HeLa cells stably 
expressing Cx26WT (77), which helps to explain why this mutation is dominant for KIDS. 
Independently, another group observed that an infant with the same mutation also exhibited central 
apnoea (78). Given the rarity of these mutations, it seems likely that Cx26 does contribute to the 
control of breathing in humans. 
 
We have further studied KIDS mutations and their effects on the CO2 sensitivity of breathing. We 
found that the mutations N14K and N14Y also abolished CO2 sensitivity of Cx26 in a dominant 
manner (79). More recently we have shown that the mutation A40V also abolishes CO2 sensitivity 
(80) (Figure 4). We have not yet tested other KIDS mutations, but as 4/9 known KIDS mutations 
abolish the CO2 sensitivity of Cx26, screening for central apnoea should be a routine part of the care 
for KIDS patients. 
 
It is important to note that the KIDS mutations have other effects on the properties of Cx26 and the 
most popular hypothesis for the aetiology of KIDS is that these mutations give a gain of function -
through causing the Cx26 hemichannels to be leaky either by reducing the strength of blockade by 
Ca2+ (81) or altering the voltage dependence of the hemichannels such they can open at more 
negative potentials (82, 83). The fact that deletion of Cx26 does not cause KIDS, gives strong 
conceptual support to the gain-of-function hypothesis. Whether the loss of CO2 sensitivity of the 
KIDS mutant hemichannels also plays a role in exacerbating the wider pathology of KIDS remains 
unclear at the moment. 
 
We have also examined whether non-syndromic mutations could alter the CO2 sensitivity of Cx26. 
Here the picture is mixed, for example: the mutation V84L has no effect on this; M34T reduces the 
extent of channel opening to CO2 but does not affect the affinity of Cx26 for CO2; A88S shifts the 
affinity of Cx26 to higher levels of CO2 but does not affect the ability of the hemichannel to open (79). 
From this, it is plausible to predict that patients carrying M34T or A88S might also have altered 
control of breathing. Note that the commonest mutations of Cx26 that cause deafness, G30del and 
G35del, prevent expression of functional Cx26. We would predict that patients with these mutations 
might also experience periods of central apnoea. We also note that specific combinations of non-
syndromic mutations might predispose patients to central apnoea: e.g. M34T/G35del; A88S/G35del. 
There are no reports in the literature of a link between hearing loss and altered control of breathing. 
This is perhaps not surprising: only certain mutations of Cx26 might have this effect; and the effects 
of these mutations might be most profound during sleep when respiratory drive is weakened and it 
depends more on inputs from central chemoreceptors. The central apnoea that can accompany 
KIDS has only recently been recognised (77, 78) and, more generally, sleep apnoea is a condition 
that can be hard to recognise without specialised measurements (84). 
 
4. Evolution of the CO2 sensitivity in  b connexins and its relevance to the control of breathing 
 
An interesting question is how the CO2 sensitivity of the b connexins (Cx26, Cx30 and Cx32) might 
have evolved. We have studied this by examining the incidence of the carbamylation motif 
throughout vertebrate phylogeny, and testing the CO2-sensitivity of connexins from a wide range of 
vertebrates (Figure 5). The Cx32 of shark possesses the carbamylation motif and has a CO2 
sensitivity indistinguishable from that of human Cx32, placing the evolution of this motif in the 
ancestor of all gnathostomes at least 450 million years ago (85). Connexin evolution has been 
characterised by genome duplications, gene losses, and a series of gene duplications (86). The 
ancestral gene of Cx32 duplicated to give the extant Cx32 and the Cx26-like gene of fish and 
amphibia (86). The carbamylation motif in the Cx26-like gene has been lost from most fish, but has 
been notably retained in lungfish, the closest extant relative to the ancestor of all tetrapods, and 
amphibia (85). While Cx26-like hemichannels from lungfish and amphibia are not CO2 sensitive, they 
differ from the Cx26 gene of mammals, birds and reptiles in having an extended C-terminus. If this 
C-terminus is truncated to the same length as the very short mammalian C-terminus then the Cx26-
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like hemichannel gains CO2-sensitivity (85). Conversely, substituting the longer Cx26-like C-
terminus for the short C-terminus of human Cx26, causes loss of the CO2 sensitivity of the 
hemichannel (85). It seems therefore that the extended C-terminus of the Cx26-like protein prevents 
hemichannel opening to CO2. However, CO2 still binds to the carbamylation motif of the Cx26-like 
protein. Instead of opening the Cx26-like hemichannel, CO2 closes the gap junction (85). 
Interestingly, Cx32 gap junctions are insensitive to moderate levels of CO2 (85). The evolution of the 
Cx26-like gene therefore gave new functionality: the ability to close a gap junction via a CO2-
dependent mechanism.  
 
During the evolution of amniotes, the Cx26-like gene further duplicated to give the Cx26 gene found 
only in amniotes and the Cx30 gene. The hemichannels of Cx30, which has a long C-terminus, are 
opened by CO2 (50). Amniote Cx26 is characterised by a short C-terminus and the near universal 
presence of the carbamylation motif (85). The Cx26 hemichannel is opened by CO2 in reptiles (turtle, 
gecko), birds (chicken) and mammals (mouse, rat, human, mole rat) and its EC50 for CO2 is tuned to 
the physiology of these animal groups (87). Gap junctions of amniote Cx26 retain the ability to close 
to CO2, and this also depends on the carbamylation motif (33). All present-day amniotes can trace 
common ancestry to those that survived the Permo-Triassic catastrophe. This geological event, 
caused by volcanic activity of the Siberian traps, occurred some 250 MYA, involved an increase in 
global temperatures of some 6oC, and resulted in extinction of more than 70% of land dwelling forms 
(88-90). Given the widespread occurrence of the truncated CO2-sensitive Cx26 in amniotes, the 
simplest hypothesis is that the occurrence of this new Cx26 variant predated this catastrophe (85). 
Whether this adaptation helped survival of these ancient amniotes during a global extinction event 
is untestable. Nevertheless, the carbamylation motif and CO2-sensitivity of Cx26 hemichannels are 
widely expressed across all present-day groups of amniotes (85, 87). As there are only two codons 
for lysine, it would be very easy to lose the carbamylation motif by genetic drift. Clearly, strong 
selection pressure has retained this motif and thus Cx26 as a CO2-sensing molecule tuned to 
respond to changes in PCO2 around the physiological norm.  
 
5. Concluding remarks 
 
Long-standing evidence in the scientific literature has supported a role for CO2 being directly 
detected by chemosensory cells and regulating breathing independently of pH. Our work has now 
provided a molecular mechanism (carbamylation of Cx26) and identified glial cells of the cPPy as 
the cellular substrate of direct CO2 chemosensing. These cells contribute nearly half of the centrally 
generated chemosensory response to modest levels of hypercapnia. Our discovery of Cx26 and 
closely related connexin as receptors for CO2 removes a conceptual barrier to thinking about CO2 
as a signalling molecule more generally in other physiological contexts. It will be very interesting to 
see whether CO2 detection by Cx26 could be involved, for example, in the regulation of blood flow, 
or be significant in the physiology of the cochlea where both Cx26 and Cx30 are strongly expressed. 
The CO2 sensitivity of Cx32 is also intriguing -this has been retained for more than 450 million years 
suggesting an important function even in fish. As Cx32 is abundantly expressed in liver, and liver 
has a significantly elevated PCO2 (91), it is tempting to speculate that CO2 could regulate Cx32 




I thank Dr Robert Huckstepp for reading a draft of this review and the Medical Research Council 









1. Milsom WK. Phylogeny of CO2/H+ chemoreception in vertebrates. Respir Physiol Neurobiol. 
2002;131(1-2):29-41. 
2. Haldane JS, Priestley JG. The regulation of the lung-ventilation. Journal of Physiology. 
1905;32(34):225-65. 
3. Lesage F. Pharmacology of neuronal background potassium channels. Neuropharmacology. 
2003;44(1):1-7. 
4. Xu H, Cui N, Yang Z, Qu Z, Jiang C. Modulation of kir4.1 and kir5.1 by hypercapnia and 
intracellular acidosis. J Physiol. 2000;524 Pt 3:725-35. 
5. Waldmann R, Champigny G, Bassilana F, Heurteaux C, Lazdunski M. A proton-gated cation 
channel involved in acid-sensing. Nature. 1997;386(6621):173-7. 
6. Waldmann R, Champigny G, Lingueglia E, De Weille JR, Heurteaux C, Lazdunski M. H(+)-
gated cation channels. Ann N Y Acad Sci. 1999;868:67-76. 
7. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, et al. Proton-sensing G-
protein-coupled receptors. Nature. 2003;425(6953):93-8. 
8. Eldridge FL, Kiley JP, Millhorn DE. Respiratory responses to medullary hydrogen ion 
changes in cats: different effects of respiratory and metabolic acidoses. J Physiol. 1985;358:285-97. 
9. Shams H. Differential effects of CO2 and H+ as central stimuli of respiration in the cat. J Appl 
Physiol. 1985;58(2):357-64. 
10. De Castro F. The discovery of sensory nature of the carotid bodies--invited article. Adv Exp 
Med Biol. 2009;648:1-18. 
11. Heymans C. Chemoreceptors and regulation of respiration. Acta Physiol Scand. 
1951;22(1):1-13. 
12. Heeringa J, Berkenbosch A, de Goede J, Olievier CN. Relative contribution of central and 
peripheral chemoreceptors to the ventilatory response to CO2 during hyperoxia. Respir Physiol. 
1979;37(3):365-79. 
13. Forster HV, Martino P, Hodges M, Krause K, Bonis J, Davis S, et al. The Carotid 
Chemoreceptors are a Major Determinant of Ventilatory CO2 Sensitivity and of PaCO2 During 
Eupneic Breathing. In: Poulin MJ, Wilson RJA, editors. Integration in Respiratory Control: From 
Genes to Systems. New York, NY: Springer New York; 2008. p. 322-6. 
14. Forster HV, Smith CA. Contributions of central and peripheral chemoreceptors to the 
ventilatory response to CO2/H+. Journal of Applied Physiology. 2010;108(4):989-94. 
15. Schuitmaker JJ, Berkenbosch A, De Goede J, Olievier CN. Effects of CO2 and H+ on the 
ventilatory response to peripheral chemoreceptor stimulation. Respir Physiol. 1986;64(1):69-79. 
16. Trapp S, Aller MI, Wisden W, Gourine AV. A role for TASK-1 (KCNK3) channels in the 
chemosensory control of breathing. J Neurosci. 2008;28(35):8844-50. 
17. Kumar NN, Velic A, Soliz J, Shi Y, Li K, Wang S, et al. Regulation of breathing by CO(2) 
requires the proton-activated receptor GPR4 in retrotrapezoid nucleus neurons. Science. 
2015;348(6240):1255-60. 
18. Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, et al. TASK channels 
determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory 
chemosensitivity. J Neurosci. 2007;27(51):14049-58. 
19. Mitchell RA, Loeschcke HH, Massion WH, Severinghaus JW. Respiratory responses 
mediated through superficial chemosensitive areas on the medulla Journal of Applied Physiology. 
1963;18:523-33. 
20. Loeschcke HH. Central chemosensitivity and the reaction theory. J Physiol. 1982;332:1-24. 
21. Schlaefke ME, See WR, Loeschcke HH. Ventilatory response to alterations of H+ ion 
concentration in small areas of the ventral medullary surface. Respir Physiol. 1970;10(2):198-212. 
22. Schlaefke ME, Kille JF, Loeschcke HH. Elimination of central chemosensitivity by coagulation 
of a bilateral area on the ventral medullary surface in awake cats. Pflugers Arch. 1979;378(3):231-
41. 
23. Trouth CO, Loeschcke HH, Berndt J. A superficial substrate on the ventral surface of the 
medulla oblongata influencing respiration. Pflugers Arch. 1973;339(2):135-52. 
24. Mulkey DK, Stornetta RL, Weston MC, Simmons JR, Parker A, Bayliss DA, et al. Respiratory 
control by ventral surface chemoreceptor neurons in rats. Nat Neurosci. 2004;7(12):1360-9. 
25. Guyenet PG, Stornetta RL, Bayliss DA. Central respiratory chemoreception. The Journal of 
comparative neurology. 2010;518(19):3883-906. 
 11 
26. Wang S, Shi Y, Shu S, Guyenet PG, Bayliss DA. Phox2b-expressing retrotrapezoid neurons 
are intrinsically responsive to H+ and CO2. J Neurosci. 2013;33(18):7756-61. 
27. Burke PG, Kanbar R, Viar KE, Stornetta RL, Guyenet PG. Selective optogenetic stimulation 
of the retrotrapezoid nucleus in sleeping rats activates breathing without changing blood pressure 
or causing arousal or sighs. J Appl Physiol (1985). 2015;118(12):1491-501. 
28. Wang S, Benamer N, Zanella S, Kumar NN, Shi Y, Bevengut M, et al. TASK-2 channels 
contribute to pH sensitivity of retrotrapezoid nucleus chemoreceptor neurons. J Neurosci. 
2013;33(41):16033-44. 
29. Hosford PS, Mosienko V, Kishi K, Jurisic G, Seuwen K, Kinzel B, et al. CNS distribution, 
signalling properties and central effects of G-protein coupled receptor 4. Neuropharmacology. 
2018;138:381-92. 
30. Wang W, Richerson GB. Chemosensitivity of non-respiratory rat CNS neurons in tissue 
culture. Brain Res. 2000;860(1-2):119-29. 
31. Richerson GB, Wang W, Tiwari J, Bradley SR. Chemosensitivity of serotonergic neurons in 
the rostral ventral medulla. Respir Physiol. 2001;129(1-2):175-89. 
32. Wang W, Tiwari JK, Bradley SR, Zaykin RV, Richerson GB. Acidosis-stimulated neurons of 
the medullary raphe are serotonergic. J Neurophysiol. 2001;85(5):2224-35. 
33. Nijjar S, Maddison D, Meigh L, de Wolf E, Rodgers T, Cann M, et al. Opposing modulation 
of Cx26 gap junctions and hemichannels by CO2. bioRxiv. 2019:584722. 
34. Iceman KE, Richerson GB, Harris MB. Medullary serotonin neurons are CO2 sensitive in situ. 
J Neurophysiol. 2013;110(11):2536-44. 
35. Iceman KE, Harris MB. A group of non-serotonergic cells is CO2-stimulated in the medullary 
raphe. Neuroscience. 2014;259:203-13. 
36. Bradley SR, Pieribone VA, Wang W, Severson CA, Jacobs RA, Richerson GB. 
Chemosensitive serotonergic neurons are closely associated with large medullary arteries. Nat 
Neurosci. 2002;5(5):401-2. 
37. Ray RS, Corcoran AE, Brust RD, Kim JC, Richerson GB, Nattie E, et al. Impaired respiratory 
and body temperature control upon acute serotonergic neuron inhibition. Science. 
2011;333(6042):637-42. 
38. Wu Y, Proch KL, Teran FA, Lechtenberg RJ, Kothari H, Richerson GB. Chemosensitivity of 
Phox2b-expressing retrotrapezoid neurons is mediated in part by input from 5-HT neurons. J Physiol. 
2019;597(10):2741-66. 
39. Gourine AV, Llaudet E, Dale N, Spyer KM. ATP is a mediator of chemosensory transduction 
in the central nervous system. Nature. 2005;436(7047):108-11. 
40. Corcoran AE, Hodges MR, Wu Y, Wang W, Wylie CJ, Deneris ES, et al. Medullary serotonin 
neurons and central CO2 chemoreception. Respir Physiol Neurobiol. 2009. 
41. da Silva GS, Moraes DJ, Giusti H, Dias MB, Glass ML. Purinergic transmission in the rostral 
but not caudal medullary raphe contributes to the hypercapnia-induced ventilatory response in 
unanesthetized rats. Respir Physiol Neurobiol. 2012;184(1):41-7. 
42. Sobrinho CR, Wenker IC, Poss EM, Takakura AC, Moreira TS, Mulkey DK. Purinergic 
signalling contributes to chemoreception in the retrotrapezoid nucleus but not the nucleus of the 
solitary tract or medullary raphe. J Physiol. 2014;592(Pt 6):1309-23. 
43. Huckstepp RT, id Bihi R, Eason R, Spyer KM, Dicke N, Willecke K, et al. Connexin 
hemichannel-mediated CO2-dependent release of ATP in the medulla oblongata contributes to 
central respiratory chemosensitivity. J Physiol. 2010;588(Pt 20):3901-20. 
44. Rash JE, Yasumura T, Davidson KG, Furman CS, Dudek FE, Nagy JI. Identification of cells 
expressing Cx43, Cx30, Cx26, Cx32 and Cx36 in gap junctions of rat brain and spinal cord. Cell 
Commun Adhes. 2001;8(4-6):315-20. 
45. Nagy JI, Rash JE. Astrocyte and oligodendrocyte connexins of the glial syncytium in relation 
to astrocyte anatomical domains and spatial buffering. Cell Commun Adhes. 2003;10(4-6):401-6. 
46. Nagy JI, Lynn BD, Tress O, Willecke K, Rash JE. Connexin26 expression in brain 
parenchymal cells demonstrated by targeted connexin ablation in transgenic mice. Eur J Neurosci. 
2011;34(2):263-71. 
47. Stout C, Goodenough DA, Paul DL. Connexins: functions without junctions. Curr Opin Cell 
Biol. 2004;16(5):507-12. 
48. Pearson RA, Dale N, Llaudet E, Mobbs P. ATP released via gap junction hemichannels from 
the pigment epithelium regulates neural retinal progenitor proliferation. Neuron. 2005;46(5):731-44. 
 12 
49. Kang J, Kang N, Lovatt D, Torres A, Zhao Z, Lin J, et al. Connexin 43 hemichannels are 
permeable to ATP. J Neurosci. 2008;28(18):4702-11. 
50. Huckstepp RT, Eason R, Sachdev A, Dale N. CO2-dependent opening of connexin 26 and 
related beta connexins. J Physiol. 2010;588(Pt 20):3921-31. 
51. Yu J, Bippes CA, Hand GM, Muller DJ, Sosinsky GE. Aminosulfonate modulated pH-induced 
conformational changes in connexin26 hemichannels. J Biol Chem. 2007;282(12):8895-904. 
52. Gourine AV, Kasymov V, Marina N, Tang F, Figueiredo MF, Lane S, et al. Astrocytes control 
breathing through pH-dependent release of ATP. Science. 2010;329(5991):571-5. 
53. Turovsky E, Theparambil SM, Kasymov V, Deitmer JW, Del Arroyo AG, Ackland GL, et al. 
Mechanisms of CO2/H+ Sensitivity of Astrocytes. J Neurosci. 2016;36(42):10750-8. 
54. Nualart-Marti A, del Molino EM, Grandes X, Bahima L, Martin-Satue M, Puchal R, et al. Role 
of connexin 32 hemichannels in the release of ATP from peripheral nerves. Glia. 2013;61(12):1976-
89. 
55. Hansen DB, Braunstein TH, Nielsen MS, MacAulay N. Distinct permeation profiles of the 
connexin 30 and 43 hemichannels. FEBS Lett. 2014;588(8):1446-57. 
56. Kilmartin JV, Rossi-Bernard L. The binding of carbon dioxide by horse haemoglobin. 
Biochemical journal. 1971;124(1):31–45. 
57. Lundqvist T, Schneider G. Crystal structure of the ternary complex of ribulose-1,5-
bisphosphate carboxylase, Mg(II), and activator CO2 at 2.3-A resolution. Biochemistry. 
1991;30(4):904-8. 
58. Maveyraud L, Golemi D, Kotra LP, Tranier S, Vakulenko S, Mobashery S, et al. Insights into 
class D beta-lactamases are revealed by the crystal structure of the OXA10 enzyme from 
Pseudomonas aeruginosa. Structure. 2000;8(12):1289-98. 
59. Golemi D, Maveyraud L, Vakulenko S, Samama JP, Mobashery S. Critical involvement of a 
carbamylated lysine in catalytic function of class D beta-lactamases. Proc Natl Acad Sci U S A. 
2001;98(25):14280-5. 
60. Lorimer GH. Carbon-Dioxide and Carbamate Formation - the Makings of a Biochemical 
Control-System. Trends in Biochemical Sciences. 1983;8(2):65-8. 
61. Meigh L. CO2 carbamylation of proteins as a mechanism in physiology. Biochem Soc Trans. 
2015;43(3):460-4. 
62. Linthwaite VL, Janus JM, Brown AP, Wong-Pascua D, O'Donoghue AC, Porter A, et al. The 
identification of carbon dioxide mediated protein post-translational modifications. Nat Commun. 
2018;9(1):3092. 
63. Meigh L, Greenhalgh SA, Rodgers TL, Cann MJ, Roper DI, Dale N. CO2 directly modulates 
connexin 26 by formation of carbamate bridges between subunits. eLife. 2013;2:e01213. 
64. Maeda S, Nakagawa S, Suga M, Yamashita E, Oshima A, Fujiyoshi Y, et al. Structure of the 
connexin 26 gap junction channel at 3.5 A resolution. Nature. 2009;458(7238):597-602. 
65. Meigh L, Cook D, Zhang J, Dale N. Rational design of new NO and redox sensitivity into 
connexin26 hemichannels. Open Biol. 2015;5(2):140208. 
66. van de Wiel J, Meigh L, Bhandare A, Cook J, Nijjar S, Huckstepp R, et al. Connexin26 
mediates CO2-dependent regulation of breathing via glial cells of the medulla oblongata. 
Communications Biology. 2020;3(1):521. 
67. Ribas-Salgueiro JL, Gaytan SP, Crego R, Pasaro R, Ribas J. Highly H+-sensitive neurons in 
the caudal ventrolateral medulla of the rat. J Physiol. 2003;549(Pt 1):181-94. 
68. Ribas-Salgueiro JL, Gaytán SP, Ribas J, Pásaro R. Characterization of efferent projections 
of chemosensitive neurons in the caudal parapyramidal area of the rat brain. Brain research bulletin. 
2005;66:235-48. 
69. Nattie EE, Li A. CO2 dialysis in the medullary raphe of the rat increases ventilation in sleep. 
J Appl Physiol. 2001;90(4):1247-57. 
70. Li A, Randall M, Nattie EE. CO(2) microdialysis in retrotrapezoid nucleus of the rat increases 
breathing in wakefulness but not in sleep. J Appl Physiol. 1999;87(3):910-9. 
71. Bevensee MO, Boron WF. Control of intracellular pH. In: Alpern RJ, Caplan MJ, Moe OW, 
editors. Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology. 5th ed. San Diego, CA: 
Academic Press; 2013. p. 1773-835. 
72. Salameh AI, Ruffin VA, Boron WF. Effects of metabolic acidosis on intracellular pH responses 
in multiple cell types2014 2014-12-15 00:00:00. R1413-R27 p. 
 13 
73. Huckstepp RT, Dale N. Redefining the components of central CO2 chemosensitivity--towards 
a better understanding of mechanism. J Physiol. 2011;589(Pt 23):5561-79. 
74. Petersen MB, Willems PJ. Non-syndromic, autosomal-recessive deafness. Clin Genet. 
2006;69(5):371-92. 
75. Wilson GN, Squires RH, Jr., Weinberg AG. Keratitis, hepatitis, ichthyosis, and deafness: 
report and review of KID syndrome. Am J Med Genet. 1991;40(3):255-9. 
76. Xu J, Nicholson BJ. The role of connexins in ear and skin physiology - functional insights 
from disease-associated mutations. Biochim Biophys Acta. 2013;1828(1):167-78. 
77. Meigh L, Hussain N, Mulkey DK, Dale N. Connexin26 hemichannels with a mutation that 
causes KID syndrome in humans lack sensitivity to CO2. eLife. 2014;3:e04249. 
78. Lilly E, Bunick CG, Maley AM, Zhang S, Spraker MK, Theos AJ, et al. More than keratitis, 
ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations. Journal of the American 
Academy of Dermatology. 2019;80(3):617-25. 
79. de Wolf E, van de Wiel J, Cook J, Dale N. Altered CO2 sensitivity of connexin26 mutant 
hemichannels in vitro. Physiol Rep. 2016;4(22):e13038. 
80. Cook J, de Wolf E, Dale N. Cx26 keratitis ichthyosis deafness syndrome mutations trigger 
alternative splicing of Cx26 to prevent expression and cause toxicity in vitro. Royal Society open 
science. 2019;6(8):191128. 
81. Mhaske PV, Levit NA, Li L, Wang HZ, Lee JR, Shuja Z, et al. The human Cx26-D50A and 
Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased 
hemichannel activity. Am J Physiol Cell Physiol. 2013;304(12):C1150-8. 
82. Sanchez HA, Slavi N, Srinivas M, Verselis VK. Syndromic deafness mutations at Asn 14 
differentially alter the open stability of Cx26 hemichannels. J Gen Physiol. 2016;148(1):25-42. 
83. Valdez Capuccino JM, Chatterjee P, Garcia IE, Botello-Smith WM, Zhang H, Harris AL, et al. 
The connexin26 human mutation N14K disrupts cytosolic intersubunit interactions and promotes 
channel opening. J Gen Physiol. 2019;151(3):328-41. 
84. Mohammadieh A, Sutherland K, Cistulli PA. Sleep disordered breathing: management 
update. Intern Med J. 2017;47(11):1241-7. 
85. Dospinescu V-M, Nijjar S, Spanos F, Cook J, de Wolf E, Biscotti MA, et al. Structural 
determinants of CO2-sensitivity in the β connexin family suggested by evolutionary analysis. 
Communications Biology. 2019;2(1):331. 
86. Cruciani V, Mikalsen SO. The vertebrate connexin family. Cell Mol Life Sci. 
2006;63(10):1125-40. 
87. de Wolf E, Cook J, Dale N. Evolutionary adaptation of the sensitivity of connexin26 
hemichannels to CO2. Proc R Soc B. 2017;284: 20162723. 
88. Erwin DH. The End-Permian Mass Extinction. Annual Review of Ecology and Systematics. 
1990;21(1):69-91. 
89. Benton MJ, Twitchett RJ. How to kill (almost) all life: the end-Permian extinction event. 
Trends in Ecology & Evolution. 2003;18(7):358-65. 
90. Sahney S, Benton MJ. Recovery from the most profound mass extinction of all time. Proc 
Biol Sci. 2008;275(1636):759-65. 
91. Hogg RJ, Pucacco LR, Carter NW, Laptook AR, Kokko JP. In situ PCO2 in the renal cortex, 
liver, muscle, and brain of the New Zealand white rabbit. Am J Physiol. 1984;247(3 Pt 2):F491-8. 
92. Fu C, Shi L, Wei Z, Yu H, Hao Y, Tian Y, et al. Activation of Phox2b-Expressing Neurons in 
the Nucleus Tractus Solitarii Drives Breathing in Mice. J Neurosci. 2019;39(15):2837-46. 
93. Alheid GF, Jiao W, McCrimmon DR. Caudal nuclei of the rat nucleus of the solitary tract 











Figure 1: Schematic of peripheral and central respiratory chemosensory nuclei. The carotid 
bodies comprise the peripheral chemosensors and contain glomus cells that respond to changes in 
arterial pH via TASK-1 channels. GPR4 is present in the carotid, but its specific contribution to pH 
sensitivity of the glomus cells has not been established. The carotid bodies project to the nucleus 
tractus solitarius (NTS) in the dorsal medulla oblongata. The NTS projects to the inspiratory rhythm 
generator (preBötzinger Complex, preBötC) (92) and the retrotrapezoid nucleus (RTN) (93). Overall 
the carotid bodies contributes to about 30% of the total adaptive ventilatory response to hypercapnia 
and mainly by evoking a compensatory increase in breathing frequency. The RTN and medullary 
raphé comprise two important chemosensory areas in the ventral medulla. Both nuclei contain pH-
sensitive neurons which detect H+ via GPR4 and additionally TASK-2 in the case of the RTN and 







Figure 2: Structure of Cx26 showing the position of residues K125 (blue) and R104 (red) that 
form the carbamate bridge. The left panel shows the view from the cytoplasmic face along the axis 
of the pore (shown open). Note how R194 and K125 of adjacent subunits point towards each other 
and are only 6.5 Å apart. The right panel shows a side view demonstrating the R104 and K125 are 







Figure 3: Revised schematic for respiratory chemosensing to incorporate direct CO2 sensing 
via Cx26. Specialised glial cells with long dorso-rostral projecting process that express Cx26 are 
found in the caudal parapyramidal area (cPPy). These processes project towards the preBötzinger 
complex (preB) and could potentially release ATP at this location to increase breathing. The 
processes also project medially and could activate the serotonergic neurons of the raphé obscurus 
(ROb) and raphé pallidus (RPa). Additionally, the cPPY contains serotonergic neurons that could be 
excited by the local release of ATP from the cPPY glial cells. As the binding site for CO2 is 
intracellular, CO2 must cross the membrane to cause Cx26 opening and allow the release of ATP. 
 
Abbreviations: VII, 7th (facial) nucleus; NA, nucleus ambiguus; py, pyramids; IO, inferior olive; LRt 










Figure 4: Location of KIDS mutations that affect CO2-sensitivity of Cx26 relative to the 
carbamylation motif. Two subunits of Cx26 are shown next to each other. On one subunit, the 
residues N14, A88 and A40 are shown in magenta.  Note that R104 and K125 form the carbamate 
bridge above the portion of the subunit that connects the N-terminal helix (coloured dark blue). N14 
is thus close to the location of the carbamate bridge helping to explain why substitution of a lysine 
(N14K) or a tyrosine (N14Y) removes CO2 sensitivity. In contrast the residues A88 and A40 are 
distant from the site of carbamylation, and it remains unclear why the mutations A88V and A40V 










Figure 5: Inferred evolution of CO2 sensitivity in b connexins. We propose that the common 
ancestor of the Cx32 and Cx26-like genes (preCx32) possessed had the carbamylation motif. The 
carbamylation motif regulated the opening of hemichannels and has been preserved in Cx32 to the 
present day. Duplication of the ancestral gene gave rise to the Cx26-like gene in which the 
carbamylation motif had a de novo function -gain of CO2-dependent gap junction closure. However, 
CO2-dependent opening was lost in the Cx26-like hemichannel. With the evolution of amniotes (grey 
dashed box), the Cx26-like gene was duplicated to give Cx26 and Cx30. Cx30 gained a long C-
terminus and in many cases lost the carbamylation motif. Cx26 in amniotes lost the C-terminus and 
regained the ability of CO2 to open the hemichannel, and retained CO2-dependent gap junction 
closure. Green box indicates near-universal presence of carbamylation motif, light green box 
presence of carbamylation motif in some species but not others. Figure reproduced from (85). 
 
 
